Lyra Therapeutics (LYRA) SEC Filings & 10K Form

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

Free LYRA Stock Alerts

$5.19

-0.20 (-3.71%)

(As of 04/19/2024 ET)

Compare

Recent Lyra Therapeutics SEC Filings

Filing Types

Ownership Filings

Time Frame

Start Date

End Date

Export to Excel

Date	Filer	Form Type
04/01/2024 11:15 PM	Lyra Therapeutics (Filer)	Form EFFECT
03/22/2024 6:38 AM	Lyra Therapeutics (Filer)	Form S-3 Registration statement under Securities Act of 1933
03/22/2024 6:41 AM	Lyra Therapeutics (Filer)	Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans
03/22/2024 5:58 AM	Lyra Therapeutics (Filer)	Form 10-K Annual report pursuant to Section 13 or 15(d)
03/20/2024 6:20 PM	Lyra Therapeutics (Issuer) Palasis Maria (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
03/20/2024 6:21 PM	Lyra Therapeutics (Issuer) Waksal Harlan (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
02/15/2024 8:18 AM	Lyra Therapeutics (Subject) PURA VIDA INVESTMENTS, LLC (Filed by)	Form SC 13G/A
Get the Latest News and Ratings for LYRA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Lyra Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
02/14/2024 7:35 PM	Lyra Therapeutics (Subject) Venrock Healthcare Capital Partners II, L.P. (Filed by)	Form SC 13G/A
02/14/2024 5:18 PM	CITADEL ADVISORS LLC (Filed by) Lyra Therapeutics (Subject)	Form SC 13G/A
01/08/2024 5:13 AM	Lyra Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
12/28/2023 5:40 AM	Lyra Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
12/18/2023 3:16 PM	Lyra Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
11/16/2023 4:00 PM	Lyra Therapeutics (Subject) Point72 Asset Management, L.P. (Filed by)	Form SC 13G
11/13/2023 4:29 PM	Lyra Therapeutics (Issuer) Waksal Harlan (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
11/07/2023 3:23 PM	Lyra Therapeutics (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
09/12/2023 3:01 PM	Lyra Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
08/25/2023 3:15 PM	Lyra Therapeutics (Subject) Samsara BioCapital, L.P. (Filed by)	Form SC 13G
07/14/2023 3:06 PM	Lyra Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
07/12/2023 5:36 PM	Lyra Therapeutics (Issuer) Palasis Maria (Reporting)	Form 4/A
07/09/2023 11:15 PM	Lyra Therapeutics (Filer)	Form EFFECT
07/07/2023 3:44 PM	Lyra Therapeutics (Filer)	Form 424B3
07/05/2023 8:53 PM	Lyra Therapeutics (Issuer) TOBIN JAMES R (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
07/05/2023 8:46 PM	Lyra Therapeutics (Issuer) snyderman nancy lynn MD (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
07/05/2023 8:46 PM	ANDERSON EDWARD T (Reporting) Lyra Therapeutics (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
07/05/2023 8:49 PM	Lyra Therapeutics (Issuer) MERRIFIELD C ANN (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
07/05/2023 8:49 PM	ALTMAN MICHAEL SETH (Reporting) Lyra Therapeutics (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
07/05/2023 8:50 PM	Lyra Therapeutics (Issuer) Poukalov Konstantin (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
07/05/2023 8:52 PM	Lyra Therapeutics (Issuer) Smith W Bradford (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
06/26/2023 4:39 PM	Lyra Therapeutics (Issuer) Palasis Maria (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
06/09/2023 4:11 PM	Lyra Therapeutics (Filer)	Form D Notice of Exempt Offering of Securities
05/31/2023 4:30 PM	Lyra Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
05/12/2023 6:09 AM	Lyra Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
05/12/2023 6:20 AM	Lyra Therapeutics (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
04/25/2023 3:11 PM	Lyra Therapeutics (Filer)	Form DEFA14A
04/25/2023 3:11 PM	Lyra Therapeutics (Filer)	Form DEFA14A

(Data available from 1/1/2016 forward)

Related Companies and Tools

Related Companies:

SEC Filings Tools:

This page (NASDAQ:LYRA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Lyra Therapeutics (LYRA) SEC Filings & 10K Form

Recent Lyra Therapeutics SEC Filings

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info